Legend Strategy Completes Auro Hong Kong Acquisition, Gains Beisheng Stake

MT Newswires Live

03/06

Legend Strategy International (HKG:1355) said it completed its acquisition of Auro Hong Kong, giving it an indirect 37.5% equity interest in Beisheng Biotechnology, according to a Friday Hong Kong bourse filing.

The deal stems from a sale and purchase agreement signed in December 2025, under which Legend Strategy agreed to acquire 100% of Auro Hong Kong and a related shareholder loan for HK$22 million.

Auro Hong Kong's principal asset is its 37.5% stake in Beisheng Biotechnology, a Shenzhen-based synthetic biology infrastructure provider specializing in strain design and fermentation process development.

Legend Strategy said the acquisition could improve research and development efficiency and reduce costs for its healthcare and beauty business.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2617685785"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2617685785\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2617685785?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-06 17:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2617685785","market":"us","top_or_hot":-1,"title":"Legend Strategy Completes Auro Hong Kong Acquisition, Gains Beisheng Stake","media":"MT Newswires Live","content":"<html><body><p> Legend <a href=\"https://laohu8.com/S/MSTR\">Strategy</a> International (HKG:1355) said it completed its acquisition of Auro Hong Kong, giving it an indirect 37.5% equity interest in Beisheng Biotechnology, according to a Friday Hong Kong bourse filing.</p><p>The deal stems from a sale and purchase agreement signed in December 2025, under which Legend <a href=\"https://laohu8.com/S/STRF\">Strategy</a> agreed to acquire 100% of Auro Hong Kong and a related shareholder loan for HK$22 million.</p><p>Auro Hong Kong's principal asset is its 37.5% stake in Beisheng Biotechnology, a Shenzhen-based synthetic biology infrastructure provider specializing in strain design and fermentation process development.</p><p>Legend Strategy said the acquisition could improve research and development efficiency and reduce costs for its healthcare and beauty business.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Legend Strategy Completes Auro Hong Kong Acquisition, Gains Beisheng Stake</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLegend Strategy Completes Auro Hong Kong Acquisition, Gains Beisheng Stake\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-03-06 17:15</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Legend <a href=\"https://laohu8.com/S/MSTR\">Strategy</a> International (HKG:1355) said it completed its acquisition of Auro Hong Kong, giving it an indirect 37.5% equity interest in Beisheng Biotechnology, according to a Friday Hong Kong bourse filing.</p><p>The deal stems from a sale and purchase agreement signed in December 2025, under which Legend <a href=\"https://laohu8.com/S/STRF\">Strategy</a> agreed to acquire 100% of Auro Hong Kong and a related shareholder loan for HK$22 million.</p><p>Auro Hong Kong's principal asset is its 37.5% stake in Beisheng Biotechnology, a Shenzhen-based synthetic biology infrastructure provider specializing in strain design and fermentation process development.</p><p>Legend Strategy said the acquisition could improve research and development efficiency and reduce costs for its healthcare and beauty business.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MSTZ","symbol_name":"2倍做空MSTR ETF-T-Rex","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2617685785","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2617685785","pubTimestamp":1772788507,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Legend Strategy International  said it completed its acquisition of Auro Hong Kong, giving it an indirect 37.5% equity interest in Beisheng Biotechnology, according to a Friday Hong Kong bourse filing.The deal stems from a sale and purchase agreement signed in December 2025, under which Legend Strategy agreed to acquire 100% of Auro Hong Kong and a related shareholder loan for HK$22 million.Auro Hong Kong's principal asset is its 37.5% stake in Beisheng Biotechnology, a Shenzhen-based synthetic biology infrastructure provider specializing in strain design and fermentation process development.Legend Strategy said the acquisition could improve research and development efficiency and reduce costs for its healthcare and beauty business.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MSTZ":"2倍做空MSTR ETF-T-Rex","BK4585":"ETF&股票定投概念","MST":"做多杠杆+收益MSTR ETF-Defiance","APED":"STKd 100% MSTR & 100% COIN ETF","WNTR":"做空MSTR期权收益策略ETF-YieldMax","MSII":"REX MSTR Growth & Income ETF","BK4516":"特朗普概念","MSTK":"Tuttle Capital MSTR 0DTE Covered Call ETF","09799":"南方两倍做多MSTR-U","MSDD":"2倍做空MSTR ETF-GraniteShares","BK4596":"哈里斯概念","MSTP":"2倍做多MSTR ETF-GraniteShares","MSTY.UK":"YIELDMAX MSTR OPTION INCOME STRATEGY ETC","BK4588":"碎股","BK1164":"酒店、度假村与豪华游轮","MSOO":"2倍上限加速MSTR ETF-Leverage Shares","3SMI.UK":"GRANITESHARES 3X SHORT MSTR DAILY ETP","07799":"南方两倍做多MSTR","BK4600":"加密货币概念","SMI3.UK":"GRANITESHARES 3X SHORT MSTR DAILY ETP","SMST":"2倍做空MSTR ETF-Defiance","MTYY":"GraniteShares YieldBOOST MSTR ETF","BK4595":"比特币概念","MSTW":"Roundhill MSTR WeeklyPay ETF","3LMI.UK":"GRANITESHARES 3X LONG MSTR DAILY ETP","IMST":"MSTR期权收益策略ETF-Bitwise","MSTX":"2倍做多MSTR ETF-Defiance","BK4023":"应用软件","01355":"朸浚国际","09399":"南方两倍做空MSTR-U","LMI3.UK":"GRANITESHARES 3X LONG MSTR DAILY ETP","MSTY":"MSTR期权收益策略ETF-YieldMax","MSST":"YieldMax MSTR Performance & Distribution Target 25 ETF","07399":"南方两倍做空MSTR"},"translate_title":"联想战略完成奥诺香港收购，获得北盛股份","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"3LMI.UK":0.6,"09399":0.6,"LMI3.UK":0.6,"MTYY":0.6,"MSOO":0.6,"WNTR":0.6,"07799":0.6,"APED":0.6,"SMI3.UK":0.6,"MSTX":0.6,"MSTY.UK":0.6,"MSST":0.6,"MSTP":0.6,"07399":0.6,"MSTK":0.6,"3SMI.UK":0.6,"MST":0.6,"SMST":0.6,"MSTW":0.6,"MSTY":0.6,"MSTZ":0.6,"IMST":0.6,"MSII":0.6,"09799":0.6,"01355":1.96,"MSDD":0.6},"content_text":"Legend Strategy International (HKG:1355) said it completed its acquisition of Auro Hong Kong, giving it an indirect 37.5% equity interest in Beisheng Biotechnology, according to a Friday Hong Kong bourse filing.The deal stems from a sale and purchase agreement signed in December 2025, under which Legend Strategy agreed to acquire 100% of Auro Hong Kong and a related shareholder loan for HK$22 million.Auro Hong Kong's principal asset is its 37.5% stake in Beisheng Biotechnology, a Shenzhen-based synthetic biology infrastructure provider specializing in strain design and fermentation process development.Legend Strategy said the acquisition could improve research and development efficiency and reduce costs for its healthcare and beauty business.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}